The APAC Chemotherapy Gowns and Gloves Market was valued at USD 113.4 million in 2025 and is projected to reach USD 218.2 million by 2035, registering a CAGR of 6.9% during the forecast period. Market growth is driven by the increasing incidence of cancer, rising chemotherapy procedures, and growing emphasis on healthcare worker safety across the region.
Rising Cancer Incidence Accelerates Demand for Chemotherapy Protective Apparel
The growing burden of cancer across the Asia Pacific region is the primary driver of the chemotherapy gowns and gloves market, as increasing chemotherapy procedures require reliable protective equipment for healthcare professionals. Besides, the expansion of oncology infrastructures and strict guidelines for handling cytotoxic drugs further increase the demand for chemotherapy-resistant gowns and gloves.
Segment-wise Market Insights
By Product Type
• AAMI Level 2: Suitable for low-risk chemotherapy handling procedures.
• AAMI Level 3: Offers enhanced protection during chemotherapy administration.
• AAMI Level 4: Provides maximum barrier against hazardous drug exposure.
• Isolation Gowns: Widely used for routine patient isolation protocols.
• Chemotherapy Gloves: Essential protection against cytotoxic drug contamination.
By Material
Gowns
• Non-Woven Fabrics: Lightweight material ensuring comfort and fluid resistance.
• Woven Fabrics: Durable option for repeated protective healthcare use.
• Coated Fabric: Superior chemical resistance for hazardous drug handling.
Gloves
• Nitrile Rubber: Preferred for chemical resistance and durability.
• Neoprene: Delivers flexibility with excellent chemical protection performance.
• Polyisoprene: Latex-like comfort without allergy-related concerns.
By End-Use
• Hospitals: Largest consumers due to high chemotherapy volumes.
• Specialty Cancer Treatment Centers: Focus on dedicated oncology treatment and safety.
• Compounding Pharmacies: Require protective gear during drug preparation.
By Sales Channel
• Online Sales: Expanding through convenient digital procurement platforms.
• Offline Sales: Preferred for institutional and bulk purchasing.
By Sterilization
• Sterile – Latex: Ensures sterile protection with latex flexibility.
• Sterile – Nitrile Rubber: Combines sterility with superior chemical resistance.
• Sterile – Others: Includes specialized sterile glove material options.
• Non-Sterile: Commonly used for low-risk handling applications.
Medline Strengthens APAC Surgical Solutions Portfolio (August 2024)
In August 2024, Medline completed the acquisition of Ecolab's APAC surgical solutions business including the Microtek™ product line which has significantly broadened its sterile drape portfolio. This acquisition also enhanced the company's OEM manufacturing capabilities and has supported its surgery room solutions across the Asia-Pacific region.
Portfolio Diversification Enhances Business Resilience
Ansell's simultaneous development on its Healthcare and Industrial business units is an excellent strategic factor reducing dependency on one revenue line. As healthcare's growth is mainly driven by the need for surgical and single-use gloves, its industrial portfolio is another strength that contributes to market dominance through advanced protective solutions for the most hazardous industries.
Key Report Attributes
• Market Size 2025: USD 113.4 Million
• Market Size 2035: USD 218.2 Million
• CAGR (2025-2035): 6.9%
• Base Year: 2024
• Market Forecast Period: 2025-2035
Industry Segmentations Growth
• By Product Type: Chemotherapy Gowns - 6.5%, Chemotherapy Gloves - 8.7%.
• By Material: Gowns - 6.5%, Gloves - 8.7%.
• By End-Use: Hospitals - 6.3%, Specialty Cancer Treatment Centers - 8.1%.
• By Sales Channel: Online Sales - 8.5%, Offline Sales - 6.5%.
• By Sterilization: Chemotherapy Gloves - 6.5%, Non-Sterile - 9.1%.
目錄 Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY ...... 22
2 MARKET INTRODUCTION ............. 25
2.1 DEFINITION ..... ..... ..... ..... ....... 25
2.2 SCOPE OF THE STUDY ..... ..... ..... ..... ....... 25
2.3 Research Objective ..... ..... ..... ..... ............ 25
2.4 MARKET STRUCTURE ..... ..... ..... ..... ......... 26
3 RESEARCH METHODOLOGY ............ 27
3.1 Overview ..... ..... ..... ..... ........... 27
3.2 DATA flow ..... ..... ..... ..... ......... 29
3.2.1 DATA MINING PROCESS ..... ..... ..... ............ 29
3.3 Purchased Database: ..... ..... ..... ..... ......... 30
3.4 Secondary Sources: ..... ..... ..... ..... ........... 31
3.4.1 SECONDARY RESEARCH DATA FLOW: ..... ..... ..... ........ 32
3.5 Primary Research: ..... ..... ..... ..... ............. 33
3.5.1 PRIMARY RESEARCH DATA FLOW: ..... ..... ..... ............. 34
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ..... ..... ..... 35
3.5.3 PRIMARY RESEARCH: COUNTRYAL COVERAGE ..... ..... ........... 35
3.6 Approaches for Market End User Estimation: ..... ..... ..... ...... 36
3.6.1 REVENUE ANALYSIS APPROACH ..... ..... ..... ..... 36
3.6.2 DATA FORECASTING ..... ..... ..... ..... . 37
3.6.3 DATA FORECASTING TECHNIQUE ..... ..... ..... ............... 37
3.7 Data modeling ..... ..... ..... ..... ........ 38
3.7.1 MICROECONOMIC FACTOR ANALYSIS: ..... ..... ..... ....... 38
3.7.2 DATA MODELING: ..... ..... ..... ..... ...... 39
4 MARKET DYNAMICS .......... 41
4.1 Introduction ..... ..... ..... ..... ...... 41
4.2 Drivers ..... ..... ..... ..... .............. 42
4.2.1 INCREASING CANCER INCIDENCE ..... ..... ..... .............. 42
4.2.2 GROWING AWARENESS OF CHEMOTHERAPY SAFETY ..... ..... ...... 43
4.2.3 ADVANCEMENTS IN HEALTHCARE INFRASTRUCTURE ..... ..... ..... 43
4.2.4 GOVERNMENT SUPPORT AND INITIATIVES..... ..... ..... . 44
4.2.5 RISING DEMAND FOR PROTECTIVE MEDICAL GEAR ..... ..... ......... 44
4.3 Restraints ..... ..... ..... ..... ......... 45
4.3.1 HIGH COST OF CHEMOTHERAPY PRODUCTS ..... ..... .............. 45
4.3.2 LIMITED PREDICTIVE ACCURACY FOR COMPLEX TOXICITY ENDPOINTS ..... ...... 46
4.3.3 REGULATORY CHALLENGES AND COMPLIANCE ISSUES ..... ..... .............. 46
4.3.4 LIMITED AWARENESS AND EDUCATION AMONG HEALTHCARE PROVIDERS ..... ...... 47
4.3.5 COMPETITION FROM ALTERNATIVE CANCER TREATMENT SOLUTIONS ..... ....... 48
4.4 Opportunity ..... ..... ..... ..... ....... 49
4.4.1 DEVELOPMENT OF SUSTAINABLE AND ECO-FRIENDLY MATERIALS ..... ............. 49
4.4.2 EXPANSION OF E-COMMERCE CHANNELS FOR MEDICAL SUPPLIES ..... ............ 49
5 MARKET FACTOR ANALYSIS ............ 51
5.1 SUPPLY Chain Analysis ..... ..... ..... ..... ...... 51
5.1.1 RAW MATERIAL SOURCING AND PROCUREMENT ..... ..... ........ 51
5.1.2 MANUFACTURING AND QUALITY ASSURANCE ..... ..... ............ 51
5.1.3 REGULATORY COMPLIANCE AND CERTIFICATION ..... ..... ...... 51
5.1.4 DISTRIBUTION AND LOGISTICS MANAGEMENT ..... ..... .......... 52
5.1.5 END-USER DEMAND AND INVENTORY MANAGEMENT ..... ..... ...... 52
5.1.6 SUPPLY CHAIN RESILIENCE AND RISK MITIGATION ..... ..... ......... 52
5.2 Porter’s Five Forces Model ..... ..... ..... ..... . 53
5.2.1 THREAT OF NEW ENTRANTS (LOW) ..... ..... ..... ........... 54
5.2.2 BARGAINING POWER OF SUPPLIERS (MODERATE TO HIGH) ..... ..... ........ 54
5.2.3 THREAT OF SUBSTITUTES (LOW) ..... ..... ..... ............... 54
5.2.4 BARGAINING POWER OF BUYERS (HIGH) ..... ..... ..... .... 55
5.2.5 INTENSITY OF RIVALRY (HIGH) ..... ..... ..... ....... 55
5.3 APAC Chemotherapy Spill Kit Volume Analysis, 2019 – 2035 (Units) ..... ..... .... 56
5.4 APAC Chemotherapy Makeshift Spill Kit Usage Analysis ..... ..... ...... 57
5.4.1 TYPICAL KIT CONTENTS (CLINICAL MINIMUM) — HOSPITAL ASSEMBLED ..... ........ 57
5.5 APAC Chemotherapy Gloves – Usage of Latex ..... ..... ..... .... 57
6 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE ........ 60
6.1 Introduction ..... ..... ..... ..... ...... 60
6.1.1 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET SIZE: MARKET ESTIMATES AND FORECAST, BY PRODUCT
TYPE, 2019 – 2035 ..... ..... ..... ..... ..... 60
6.2 CHEMOTHERAPY GOWNS ..... ..... ..... ..... .. 61
6.3 CHEMOTHERAPY GLOVES ..... ..... ..... ..... . 62
7 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL ............. 63
7.1 Introduction ..... ..... ..... ..... ...... 63
7.1.1 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET SIZE: MARKET ESTIMATES AND FORECAST, BY
MATERIALS, 2019 – 2035 ..... ..... ..... ..... ............ 63
7.2 GLOVES ..... ..... ..... ..... ............ 65
7.3 GOWNS ..... ..... ..... ..... ............. 65
8 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USER ............. 66
8.1 Introduction ..... ..... ..... ..... ...... 66
8.1.1 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET SIZE: MARKET ESTIMATES AND FORECAST, BY END-USER,
2019 – 2035 ..... ..... ..... ..... ............... 66
8.2 Hospitals ..... ..... ..... ..... .......... 67
8.3 Specialty Cancer Treatment Centers ..... ..... ..... ........ 68
8.4 Compounding Pharmacies ..... ..... ..... ..... . 68
9 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL ....... 70
9.1 Introduction ..... ..... ..... ..... ...... 70
9.1.1 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET SIZE: MARKET ESTIMATES AND FORECAST, BY SALES
CHANNEL, 2019 – 2035 ..... ..... ..... ..... .............. 70
9.2 Online ..... ..... ..... ..... ............... 71
9.3 Offline ..... ..... ..... ..... ............... 72
10 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERLIZATION ...... 73
10.1 Introduction ..... ..... ..... ..... ...... 73
10.1.1 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET SIZE: MARKET ESTIMATES AND FORECAST, BY
STERILIZATION, 2019 – 2035 ..... ..... ..... ..... ...... 73
11 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY COUNTRY .............. 75
11.1 Introduction ..... ..... ..... ..... ...... 75
11.2 New Zealand ..... ..... ..... ..... ..... 76
11.2.1 MARKET SHARE ANALYSIS – GLOVES ..... ..... ..... ........ 76
11.2.2 MARKET SHARE ANALYSIS – GOWNS ..... ..... ..... ........ 76
11.2.3 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE,
2019 – 2035 ..... ..... ..... ..... ............... 77
11.2.4 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 – 2035 78
11.2.5 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 – 2035 79
11.2.6 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES
CHANNEL, 2019 – 2035 ..... ..... ..... ..... .............. 79
11.3 India ..... ..... ..... ..... ..... . 82
11.3.1 MARKET SHARE ANALYSIS – GLOVES ..... ..... ..... ........ 82
11.3.2 MARKET SHARE ANALYSIS – GOWNS ..... ..... ..... ........ 82
11.3.3 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE, 2019 –
2035 83
11.3.4 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 – 2035
84
11.3.5 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 – 2035
85
11.3.6 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL, 2019 –
2035 85
11.4 Japan ..... ..... ..... ..... ............... 87
11.4.1 MARKET SHARE ANALYSIS – GLOVES ..... ..... ..... ........ 87
11.4.2 MARKET SHARE ANALYSIS – GOWNS ..... ..... ..... ........ 88
11.4.3 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE, 2019 –
2035 88
11.4.4 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 – 2035
89
11.4.5 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 – 2035
90
11.4.6 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL, 2019 – 2035 91
11.5 South Korea ..... ..... ..... ..... ...... 93
11.5.1 MARKET SHARE ANALYSIS – GLOVES ..... ..... ..... ........ 93
11.5.2 MARKET SHARE ANALYSIS – GOWNS ..... ..... ..... ........ 93
11.5.3 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE,
2019 – 2035 ..... ..... ..... ..... ............... 94
11.5.4 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 – 2035 95
11.5.5 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 – 2035 96
11.5.6 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL,
2019 – 2035 ..... ..... ..... ..... ............... 96
11.6 Malaysia ..... ..... ..... ..... ........... 99
11.6.1 MARKET SHARE ANALYSIS – GLOVES ..... ..... ..... ........ 99
11.6.2 MARKET SHARE ANALYSIS – GOWNS ..... ..... ..... ........ 99
11.6.3 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE,
2019 – 2035 ..... ..... ..... ..... ............... 100
11.6.4 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 –
2035 101
11.6.5 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 –
2035 102
11.6.6 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL,
2019 – 2035 ..... ..... ..... ..... ............... 102
11.7 Australia ..... ..... ..... ..... ........... 105
11.7.1 MARKET SHARE ANALYSIS – GLOVES ..... ..... ..... ........ 105
11.7.2 MARKET SHARE ANALYSIS – GOWNS ..... ..... ..... ........ 105
11.7.3 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE,
2019 – 2035 ..... ..... ..... ..... ............... 106
11.7.4 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 –
2035 107
11.7.5 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 –
2035 108
11.7.6 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL,
2019 – 2035 ..... ..... ..... ..... ............... 108
11.8 Hong Kong ..... ..... ..... ..... ........ 110
11.8.1 MARKET SHARE ANALYSIS – GLOVES ..... ..... ..... ........ 110
11.8.2 MARKET SHARE ANALYSIS – GOWNS ..... ..... ..... ........ 111
11.8.3 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE,
2019 – 2035 ..... ..... ..... ..... ............... 111
11.8.4 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 –
2035 112
11.8.5 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 –
2035 113
11.8.6 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL,
2019 – 2035 ..... ..... ..... ..... ............... 114
11.9 Singapore ..... ..... ..... ..... .......... 116
11.9.1 MARKET SHARE ANALYSIS – GLOVES ..... ..... ..... ........ 116
11.9.2 MARKET SHARE ANALYSIS – GOWNS ..... ..... ..... ........ 116
11.9.3 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE,
2019 – 2035 ..... ..... ..... ..... ............... 117
11.9.4 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 –
2035 118
11.9.5 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 –
2035 119
11.9.6 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL,
2019 – 2035 ..... ..... ..... ..... ............... 120
11.10 Rest of APAC ..... ..... ..... ..... ......... 122
11.10.1 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY PRODUCT TYPE,
2019 – 2035 ..... ..... ..... ..... ............... 122
11.10.2 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2019 – 2035 123
11.10.3 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY END-USER, 2019 – 2035 124
11.10.4 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET ESTIMATES AND FORECAST, BY SALES CHANNEL,
2019 – 2035 ..... ..... ..... ..... ............... 124
12 COMPETITIVE LANDSCAPE .............. 127
12.1 Introduction ..... ..... ..... ..... ...... 127
12.2 Market Share Analysis, 2025 ..... ..... ..... .............. 127
12.3 competitor dashboard..... ..... ..... ..... ........ 128
12.4 KEY DEVELOPMENTS & GROWTH STRATEGIES ..... ..... ..... ... 129
13 COMPANY PROFILES ........ 130
13.1 Ansell ..... ..... ..... ..... ............... 130
13.1.1 COMPANY OVERVIEW ..... ..... ..... ..... 130
13.1.2 FINANCIAL OVERVIEW ..... ..... ..... ............... 131
13.1.3 PRODUCTS OFFERED ..... ..... ..... ..... . 132
13.1.4 SWOT ANALYSIS ..... ..... ..... ..... ....... 135
13.1.5 KEY STRATEGY..... ..... ..... ..... .......... 135
13.2 Careon ..... ..... ..... ..... .............. 136
13.2.1 COMPANY OVERVIEW ..... ..... ..... ..... 136
13.2.2 FINANCIAL OVERVIEW ..... ..... ..... ............... 137
13.2.3 PRODUCTS OFFERED ..... ..... ..... ..... . 137
13.2.4 SWOT ANALYSIS ..... ..... ..... ..... ....... 137
13.2.5 KEY STRATEGY..... ..... ..... ..... .......... 138
13.3 Cardinal Health ..... ..... ..... ..... ....... 139
13.3.1 COMPANY OVERVIEW ..... ..... ..... ..... 139
13.3.2 FINANCIAL OVERVIEW ..... ..... ..... ............... 140
13.3.3 PRODUCT OFFERED ..... ..... ..... ..... ... 141
13.3.4 SWOT ANALYSIS ..... ..... ..... ..... ....... 141
13.3.5 KEY STRATEGY..... ..... ..... ..... .......... 142
13.4 Owens & Minor, Inc. (Halyard) ..... ..... ..... ............ 143
13.4.1 COMPANY OVERVIEW ..... ..... ..... ..... 143
13.4.2 FINANCIAL OVERVIEW ..... ..... ..... ............... 144
13.4.3 PRODUCTS OFFERED ..... ..... ..... ..... . 145
13.4.4 SWOT ANALYSIS ..... ..... ..... ..... ....... 146
13.4.5 KEY STRATEGY..... ..... ..... ..... .......... 146
13.5 Hartalega ..... ..... ..... ..... .......... 147
13.5.1 COMPANY OVERVIEW ..... ..... ..... ..... 147
13.5.2 FINANCIAL OVERVIEW ..... ..... ..... ............... 148
13.5.3 PRODUCT OFFERED ..... ..... ..... ..... ... 149
13.5.4 SWOT ANALYSIS ..... ..... ..... ..... ....... 149
13.6 Kanam Latex Industries Pvt. Ltd ..... ..... ..... ......... 150
13.6.1 COMPANY OVERVIEW ..... ..... ..... ..... 150
13.6.2 PRODUCT OFFERED ..... ..... ..... ..... ... 151
13.6.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 151
13.6.4 KEY STRATEGY..... ..... ..... ..... .......... 152
13.7 Medicom ..... ..... ..... ..... ........... 153
13.7.1 COMPANY OVERVIEW ..... ..... ..... ..... 153
13.7.2 PRODUCT OFFERED ..... ..... ..... ..... ... 154
13.7.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 155
13.7.4 KEY STRATEGY..... ..... ..... ..... .......... 155
13.8 Medline Industries ..... ..... ..... ..... ............. 156
13.8.1 COMPANY OVERVIEW ..... ..... ..... ..... 156
13.8.2 PRODUCT OFFERED ..... ..... ..... ..... ... 157
13.8.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 157
13.8.4 KEY STRATEGY..... ..... ..... ..... .......... 158
13.9 Mun APAC Sdn Bhd ..... ..... ..... ..... ........... 159
13.9.1 COMPANY OVERVIEW ..... ..... ..... ..... 159
13.9.2 PRODUCT OFFERED ..... ..... ..... ..... ... 159
13.9.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 160
13.10 Medtecs ..... ..... ..... ..... ............ 161
13.10.1 COMPANY OVERVIEW ..... ..... ..... ..... 161
13.10.2 FINANCIAL OVERVIEW ..... ..... ..... ............... 162
13.10.3 PRODUCT OFFERED ..... ..... ..... ..... ... 163
13.10.4 SWOT ANALYSIS ..... ..... ..... ..... ....... 163
13.10.5 KEY STRATEGY..... ..... ..... ..... .......... 164
13.11 Multigate ..... ..... ..... ..... .......... 165
13.11.1 COMPANY OVERVIEW ..... ..... ..... ..... 165
13.11.2 PRODUCT OFFERED ..... ..... ..... ..... ... 165
13.11.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 166
13.12 Osaki ..... ..... ..... ..... ..... 167
13.12.1 COMPANY OVERVIEW ..... ..... ..... ..... 167
13.12.2 PRODUCT OFFERED ..... ..... ..... ..... ... 168
13.12.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 168
13.13 Saraya ..... ..... ..... ..... .............. 169
13.13.1 COMPANY OVERVIEW ..... ..... ..... ..... 169
13.13.2 PRODUCT OFFERED ..... ..... ..... ..... ... 170
13.13.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 170
13.14 SENTRY ..... ..... ..... ..... ............ 171
13.14.1 COMPANY OVERVIEW ..... ..... ..... ..... 171
13.14.2 PRODUCT OFFERED ..... ..... ..... ..... ... 171
13.14.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 172
13.14.4 KEY STRATEGY..... ..... ..... ..... .......... 172
13.15 Taketora ..... ..... ..... ..... ........... 173
13.15.1 COMPANY OVERVIEW ..... ..... ..... ..... 173
13.15.2 PRODUCT OFFERED ..... ..... ..... ..... ... 174
13.15.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 174
13.16 Top Glove ..... ..... ..... ..... .......... 175
13.16.1 COMPANY OVERVIEW ..... ..... ..... ..... 175
13.16.2 FINANCIAL OVERVIEW ..... ..... ..... ............... 176
13.16.3 PRODUCT OFFERED ..... ..... ..... ..... ... 177
13.16.4 SWOT ANALYSIS ..... ..... ..... ..... ....... 178
13.16.5 KEY STRATEGY..... ..... ..... ..... .......... 178
13.17 UltraHealth ..... ..... ..... ..... ........ 179
13.17.1 COMPANY OVERVIEW ..... ..... ..... ..... 179
13.17.2 PRODUCT OFFERED ..... ..... ..... ..... ... 180
13.17.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 180
13.18 USL Medical ..... ..... ..... ..... ...... 181
13.18.1 COMPANY OVERVIEW ..... ..... ..... ..... 181
13.18.2 PRODUCT OFFERED ..... ..... ..... ..... ... 181
13.18.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 182
13.19 Interlab Ltd ..... ..... ..... ..... ........ 183
13.19.1 COMPANY OVERVIEW ..... ..... ..... ..... 183
13.19.2 PRODUCT OFFERED ..... ..... ..... ..... ... 183
13.19.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 184
13.20 Jackson Allison Medical Supplies ..... ..... ..... ....... 185
13.20.1 COMPANY OVERVIEW ..... ..... ..... ..... 185
13.20.2 PRODUCT OFFERED ..... ..... ..... ..... ... 186
13.20.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 186
13.21 Sri Trang Gloves ..... ..... ..... ..... ..... 187
13.21.1 COMPANY OVERVIEW ..... ..... ..... ..... 187
13.21.2 FINANCIAL OVERVIEW ..... ..... ..... ............... 188
13.21.3 PRODUCT OFFERED ..... ..... ..... ..... ... 188
13.21.4 SWOT ANALYSIS ..... ..... ..... ..... ....... 189
13.22 Blossom Disposables ..... ..... ..... ..... ........ 190
13.22.1 COMPANY OVERVIEW ..... ..... ..... ..... 190
13.22.2 PRODUCT OFFERED ..... ..... ..... ..... ... 190
13.22.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 191
13.23 Kossan Rubber Industries Bhd ..... ..... ..... ............ 192
13.23.1 COMPANY OVERVIEW ..... ..... ..... ..... 192
13.23.2 FINANCIAL OVERVIEW ..... ..... ..... ............... 193
13.23.3 PRODUCT OFFERED ..... ..... ..... ..... ... 193
13.23.4 SWOT ANALYSIS ..... ..... ..... ..... ....... 194
13.24 Hubei Kangning Protective Products Co., Ltd ..... ..... ..... ...... 195
13.24.1 COMPANY OVERVIEW ..... ..... ..... ..... 195
13.24.2 PRODUCT OFFERED ..... ..... ..... ..... ... 195
13.24.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 196
13.25 Kannam Surgicare ..... ..... ..... ..... ............. 197
13.25.1 COMPANY OVERVIEW ..... ..... ..... ..... 197
13.25.2 PRODUCT OFFERED ..... ..... ..... ..... ... 198
13.25.3 SWOT ANALYSIS ..... ..... ..... ..... ....... 199
13.25.4 KEY STRATEGY..... ..... ..... ..... .......... 199
13.26 Mölnlycke Health Care AB ..... ..... ..... ..... .. 200
13.26.1 COMPANY OVERVIEW ..... ..... ..... ..... 200
13.26.2 PRODUCT OFFERED ..... ..... ..... ..... ... 201
13.26.3 FINANCIAL OVERVIEW ..... ..... ..... ............... 202
13.26.4 SWOT ANALYSIS ..... ..... ..... ..... ....... 202
13.26.5 KEY STRATEGY..... ..... ..... ..... .......... 203
13.27 Data Citations ..... ..... ..... ..... ........ 204
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 ASIA PACIFIC CHEMOTHERAPY SPILL KIT MARKET, BY PRODUCT TYPE, 2019-2035 (UNITS) 56
TABLE 2 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 60
TABLE 3 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (UNITS) 61
TABLE 4 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 63
TABLE 5 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (UNITS) 64
TABLE 6 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 66
TABLE 7 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (UNITS) 66
TABLE 8 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 70
TABLE 9 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (UNITS) 70
TABLE 10 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (USD MILLION) 73
TABLE 11 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (UNITS) 74
TABLE 12 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 77
TABLE 13 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (UNITS) 77
TABLE 14 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 78
TABLE 15 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (UNITS) 78
TABLE 16 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 79
TABLE 17 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (UNITS) 79
TABLE 18 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 79
TABLE 19 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (UNITS) 80
TABLE 20 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (USD MILLION) 80
TABLE 21 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (UNITS) 81
TABLE 22 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 83
TABLE 23 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (UNITS) 83
TABLE 24 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 84
TABLE 25 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (UNITS) 84
TABLE 26 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 85
TABLE 27 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (UNITS) 85
TABLE 28 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 85
TABLE 29 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (UNITS) 86
TABLE 30 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (USD MILLION) 86
TABLE 31 INDIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (UNITS) 87
TABLE 32 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 88
TABLE 33 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (UNITS) 89
TABLE 34 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 89
TABLE 35 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (UNITS) 90
TABLE 36 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 90
TABLE 37 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (UNITS) 91
TABLE 38 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 91
TABLE 39 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (UNITS) 91
TABLE 40 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (USD MILLION) 92
TABLE 41 JAPAN CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (UNITS) 92
TABLE 42 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 94
TABLE 43 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (UNITS) 94
TABLE 44 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 95
TABLE 45 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (UNITS) 95
TABLE 46 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 96
TABLE 47 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (UNITS) 96
TABLE 48 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 96
TABLE 49 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (UNITS) 97
TABLE 50 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (USD MILLION) 97
TABLE 51 SOUTH KOREA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (UNITS) 98
TABLE 52 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 100
TABLE 53 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (UNITS) 100
TABLE 54 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 101
TABLE 55 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (UNITS) 101
TABLE 56 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 102
TABLE 57 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (UNITS) 102
TABLE 58 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 102
TABLE 59 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (UNITS) 103
TABLE 60 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (USD MILLION) 103
TABLE 61 MALAYSIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (UNITS) 104
TABLE 62 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 106
TABLE 63 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (UNITS) 106
TABLE 64 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 107
TABLE 65 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (UNITS) 107
TABLE 66 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 108
TABLE 67 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (UNITS) 108
TABLE 68 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 108
TABLE 69 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (UNITS) 109
TABLE 70 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (USD MILLION) 109
TABLE 71 AUSTRALIA CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (UNITS) 110
TABLE 72 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 111
TABLE 73 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (UNITS) 112
TABLE 74 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 112
TABLE 75 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (UNITS) 113
TABLE 76 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 113
TABLE 77 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (UNITS) 114
TABLE 78 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 114
TABLE 79 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (UNITS) 114
TABLE 80 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (USD MILLION) 115
TABLE 81 HONG KONG CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (UNITS) 115
TABLE 82 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 117
TABLE 83 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (UNITS) 117
TABLE 84 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 118
TABLE 85 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (UNITS) 118
TABLE 86 NEW ZEALAND CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 119
TABLE 87 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (UNITS) 119
TABLE 88 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 120
TABLE 89 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (UNITS) 120
TABLE 90 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (USD MILLION) 120
TABLE 91 SINGAPORE CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (UNITS) 121
TABLE 92 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (USD MILLION) 122
TABLE 93 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2019-2035 (UNITS) 122
TABLE 94 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (USD MILLION) 123
TABLE 95 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2019-2035 (UNITS) 123
TABLE 96 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (USD MILLION) 124
TABLE 97 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2019-2035 (UNITS) 124
TABLE 98 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (USD MILLION) 124
TABLE 99 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2019-2035 (UNITS) 125
TABLE 100 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (USD MILLION) 125
TABLE 101 REST OF APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2019-2035 (UNITS) 126
TABLE 102 KEY DEVELOPMENT 129
TABLE 103 ANSELL: PRODUCT OFFERED 132
TABLE 104 CAREON: PRODUCT OFFERED 137
TABLE 105 CARDINAL HEALTH: PRODUCT OFFERED 141
TABLE 106 OWENS & MINOR, INC: PRODUCT OFFERED 145
TABLE 107 HARTALEGA: PRODUCT OFFERED 149
TABLE 108 KANAM LATEX INDUSTRIES PVT. LTD: PRODUCT OFFERED 151
TABLE 109 MEDICOM: PRODUCT OFFERED 154
TABLE 110 MEDLINE INDUSTRIES : PRODUCT OFFERED 157
TABLE 111 MUN APAC SDN BHD: PRODUCT OFFERED 159
TABLE 112 MEDTECS: PRODUCT OFFERED 163
TABLE 113 MULTIGATE: PRODUCT OFFERED 165
TABLE 114 OSAKI: PRODUCT OFFERED 168
TABLE 115 SARAYA: PRODUCT OFFERED 170
TABLE 116 SENTRY: PRODUCT OFFERED 171
TABLE 117 TAKETORA: PRODUCT OFFERED 174
TABLE 118 TOP GLOVE: PRODUCT OFFERED 177
TABLE 119 ULTRAHEALTH: PRODUCT OFFERED 180
TABLE 120 USL MEDICAL: PRODUCT OFFERED 181
TABLE 121 INTERLAB LTD: PRODUCT OFFERED 183
TABLE 122 JACKSON ALLISON MEDICAL SUPPLIES: PRODUCT OFFERED 186
TABLE 123 TOP GLOVE: PRODUCT OFFERED 188
TABLE 124 BLOSSOM DISPOSABLES : PRODUCT OFFERED 190
TABLE 125 KOSSAN RUBBER INDUSTRIES BHD: PRODUCT OFFERED 193
TABLE 126 HUBEI KANGNING PROTECTIVE PRODUCTS CO., LTD: PRODUCT OFFERED 195
TABLE 127 KANNAM SURGICARE: PRODUCT OFFERED 198
TABLE 128 MÖLNLYCKE HEALTH CARE AB: PRODUCT OFFERED 201
LIST OF FIGURES
FIGURE 1 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET: STRUCTURE 26
FIGURE 2 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET: GROWTH FACTOR ANALYSIS 42
FIGURE 3 DRIVER IMPACT ANALYSIS (2019-2035) 45
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2019-2035) 48
FIGURE 5 PORTER’S FIVE FORCES MODEL: ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET 53
FIGURE 6 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY PRODUCT TYPE, 2025 (% SHARE) 61
FIGURE 7 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY MATERIAL, 2025 (% SHARE) 64
FIGURE 8 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY END USE, 2025 (% SHARE) 67
FIGURE 9 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY SALES CHANNEL, 2025 (% SHARE) 71
FIGURE 10 ASIA PACIFIC CHEMOTHERAPY GOWNS AND GLOVES MARKET, BY STERILIZATION, 2025 (% SHARE) 74
FIGURE 11 NEW ZEALAND CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2025 76
FIGURE 12 NEW ZEALAND CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2025 76
FIGURE 13 INDIA CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2025 82
FIGURE 14 INDIA CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2025 82
FIGURE 15 JAPAN CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2025 87
FIGURE 16 JAPAN CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2025 88
FIGURE 17 SOUTH KOREA CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2025 93
FIGURE 18 SOUTH KOREA CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2025 93
FIGURE 19 MALAYSIA CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2025 99
FIGURE 20 MALAYSIA CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2025 99
FIGURE 21 AUSTRALIA CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2025 105
FIGURE 22 AUSTRALIA CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2025 105
FIGURE 23 HONG KONG CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2025 110
FIGURE 24 HONG KONG CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2025 111
FIGURE 25 SINGAPORE CHEMOTHERAPY GLOVES MARKET SHARE ANALYSIS, 2025 116
FIGURE 26 SINGAPORE CHEMOTHERAPY GOWNS MARKET SHARE ANALYSIS, 2025 116
FIGURE 27 APAC CHEMOTHERAPY GOWNS AND GLOVES MARKET: COMPETITIVE ANALSIS, 2025 127
FIGURE 28 COMPETITOR DASHBOARD: APAC SURGICAL GOWNS AND DRAPES MARKET 128
FIGURE 29 ANSELL: SWOT ANALYSIS 135
FIGURE 30 CAREON: SWOT ANALYSIS 137
FIGURE 31 CARDINAL HEALTH: SWOT ANALYSIS 141
FIGURE 32 OWENS & MINOR, INC : SWOT ANALYSIS 146
FIGURE 33 HARTALEGA: SWOT ANALYSIS 149
FIGURE 34 KANAM LATEX INDUSTRIES PVT. LTD: SWOT ANALYSIS 151
FIGURE 35 MEDICOM: SWOT ANALYSIS 155
FIGURE 36 MEDLINE INDUSTRIES : SWOT ANALYSIS 157
FIGURE 37 MUN APAC SDN BHD: SWOT ANALYSIS 160
FIGURE 38 MEDTECS: SWOT ANALYSIS 163
FIGURE 39 MULTIGATE: SWOT ANALYSIS 166
FIGURE 40 OSAKI: SWOT ANALYSIS 168
FIGURE 41 SARAYA: SWOT ANALYSIS
FIGURE 42 SENTRY: SWOT ANALYSIS
FIGURE 43 TAKETORA: SWOT ANALYSIS
FIGURE 44 TOP GLOVE: SWOT ANALYSIS
FIGURE 45 ULTRAHEALTH: SWOT ANALYSIS
FIGURE 46 USL MEDICAL: SWOT ANALYSIS
FIGURE 47 INTERLAB LTD: SWOT ANALYSIS
FIGURE 48 JACKSON ALLISON MEDICAL SUPPLIES: SWOT ANALYSIS
FIGURE 49 SRI TRANG GLOVES: SWOT ANALYSIS
FIGURE 50 BLOSSOM DISPOSABLES : SWOT ANALYSIS
FIGURE 51 KOSSAN RUBBER INDUSTRIES BHD: SWOT ANALYSIS
FIGURE 52 HUBEI KANGNING PROTECTIVE PRODUCTS CO., LTD: SWOT ANALYSIS
FIGURE 53 KANNAM SURGICARE: SWOT ANALYSIS
FIGURE 54 MÖLNLYCKE HEALTH CARE AB: SWOT ANALYSI
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們